UBS Group’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-36,700
Closed -$568K 9416
2023
Q4
$568K Hold
36,700
﹤0.01% 5005
2023
Q3
$503K Buy
+36,700
New +$540K ﹤0.01% 4647

Other funds holding CYRX

UBS Group's CYRX Position: Q1 2026 in Review

UBS Group reduced its CryoPort (CYRX) stake by 34% in Q1 2026, selling an estimated $4.42M and leaving 932,782 shares worth $7.72M. The position accounts for ﹤0.01% of the portfolio, ranked #3626.

UBS Group first reported a position in CYRX in Q3 2015 and has held it in 38 quarters since. The position peaked at $13.7M in Q4 2025. 165 funds tracked by Wall St. Rank hold CYRX as of Q1 2026.

  • UBS Group held 932,782 shares of CryoPort worth $7.72M as of Q1 2026.
  • UBS Group sold 489,102 CryoPort shares in Q1 2026, an estimated $4.42M.
  • CryoPort made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3626 holding.
  • UBS Group first reported a position in CryoPort in Q3 2015 and has held it in 38 quarters since.
  • UBS Group's CryoPort position peaked at $13.7M in Q4 2025.
  • 165 funds tracked by Wall St. Rank held CryoPort as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.